ALEXANDRIA REAL EST. EQU./ US0152711091 /
7/25/2024 3:29:01 PM | Chg. -4.8500 | Volume | Bid9:59:58 PM | Ask9:59:58 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
105.5500EUR | -4.39% | 46 Turnover: 4,931.2000 |
-Bid Size: - | -Ask Size: - | 18.72 bill.EUR | - | - |
GlobeNewswire
10/20/2023
SHARC Energy at Forefront of Alexandria’s Sustainable Mega Campus Initiative
GlobeNewswire
9/21/2023
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross
GlobeNewswire
2/23/2022
Intellia Therapeutics Enters Lease Agreement to Build Manufacturing Facility for its CRISPR-based Th...
GlobeNewswire
10/21/2021
Orange Grove Bio, AlleyCorp and Alexandria Venture Investments Establish Partnership with Albert Ein...
GlobeNewswire
9/21/2021
Adaptive Biotechnologies Announces Grand Opening of State-of-the-Art Headquarters and Expands Footpr...
GlobeNewswire
5/13/2021
TCR² Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire
3/29/2021
TCR² Therapeutics Establishes Commercial-Scale Cell Therapy Manufacturing Facility
GlobeNewswire
2/24/2021
Life Science Cares and Biogen Foundation Help Launch Food For Free’s Just Eats Program
GlobeNewswire
8/12/2020
Beam Therapeutics Announces First Development Candidates for Sickle Cell Disease and Reports Second ...
GlobeNewswire
11/14/2019
Sarepta and StrideBio Announce Multi-target Strategic Collaboration to Advance Novel Gene Therapies